Madison Muller

1 week ago | bloomberg.com | Madison Muller |Gerry Smith

The Moderna headquarters in Cambridge, Massachusetts. (Bloomberg) -- US health officials are terminating a contract with Moderna Inc. worth up to $766 million to develop vaccines for bird flu, a major setback for the company as it faces additional government scrutiny over immunizations. Moderna said in a statement Wednesday that the vaccine was shown to be safe and well-tolerated in early clinical studies.

2 weeks ago | bloomberg.com | Madison Muller

Wegovy injection pens. (Bloomberg) -- Novo Nordisk A/S is selling its blockbuster weight-loss drug Wegovy to new patients at $199 for the first month as easy access to cheaper copycats comes to an end. The one-time offer — available through June 30 — is intended for patients who were taking copycat, or compounded, versions of Wegovy. After that, it will cost $499 a month for self-paying customers.

3 weeks ago | news.bloombergtax.com | Tanaz Meghjani |Biz Carson |Madison Muller

XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.

3 weeks ago | news.bloomberglaw.com | Tanaz Meghjani |Biz Carson |Madison Muller

The success of Eli Lilly & Co.'s weight-loss and diabetes drugs has pushed the company’s stock to new heights, helping the founding family’s endowment become the largest private foundation in the US. At the end of 2024, the Lilly Endowment had $79.9 billion in assets, according to filings released Friday. That’s about a 29% jump from a year earlier, topping the $77.2 billion of the Gates Foundation, which had held the top spot for several years.

3 weeks ago | bloomberg.com | Tanaz Meghjani |Biz Carson |Madison Muller

Eli Lilly & Co.’s stock soared after the company’s drug Mounjaro was approved by the US Food and Drug Administration. (Bloomberg) -- The success of Eli Lilly & Co.'s weight-loss and diabetes drugs has pushed the company's stock to new heights, helping the founding family's endowment become the largest private foundation in the US. At the end of 2024, the Lilly Endowment had $79.9 billion in assets, according to filings released Friday.